Squalamine

Squalamine

SCHEMBL21248627

CC(C)C(CCC(C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@@H](NCCCNCCCCN)CC[C@]4(C)[C@H]3CC[C@]12C)OS(=O)(=O)O

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC9A3

The experimentally established mechanism targets of Squalamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.97
NR1H4 Q96RI1 8/20 0.53
SLC10A1 Q14973 3/20 0.51
GPBAR1 Q8TDU6 9/20 0.51
SLC10A2 Q12908 2/20 0.48
ABCC4 O15439 1/20 0.48
ABCB11 O95342 1/20 0.48
PLA2G1B P04054 1/20 0.48
ENPP2 Q13822 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Squalamine SCHEMBL14441307 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2
Squalamine SCHEMBL17359656 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2
Squalamine SCHEMBL16072074 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2
Squalamine SCHEMBL13294189 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2
Squalamine SCHEMBL14430016 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2
Squalamine SCHEMBL12836 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2
Squalamine SCHEMBL18838926 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2
Squalamine SCHEMBL22356672 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2
Squalamine SCHEMBL20850040 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2
Squalamine SCHEMBL13014098 1.00 PTPN1 (0.97) PTPN1NR1H4SLC10A1GPBAR1SLC10A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3749633-A1 TARGETING OCULAR DISEASES WITH NOVEL APE1/REF-1 INHIBITORS Indiana University Research and Technology Corporation (US) 2020-12-16 EP disclosed
US-10752901-B2 Inhibition of ferrochelatase as an antiangiogenic therapy INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2020-08-25 US disclosed
WO-2019157163-A1 TARGETING OCULAR DISEASES WITH NOVEL APE1/REF-1 INHIBITORS INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2019-08-15 WO disclosed